Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,534Diabetes Management and ResearchRetinal Diseases and TreatmentsChronic Kidney Disease and Diabetes

The DOI matches its Crossref record, with a small difference in title or year; 22 of the 22 references it cites were found in a registry or an index.

Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy

Open access
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group·2000·New England Journal of Medicine

Abstract

BACKGROUND: Among patients with type 1 diabetes mellitus, intensive therapy (with the aim of achieving near-normal blood glucose and glycosylated hemoglobin concentrations [hemoglobin A1c]) markedly reduces the risk of microvascular complications as compared with conventional therapy. To assess whether these benefits persist, we compared the effects of former and intensive conventional therapy on the recurrence and severity of retinopathy and nephropathy for four years after the end of the Diabetes Control and Complications Trial (DCCT). METHODS: At the end of the DCCT, the patients in the conventional-therapy group were offered intensive therapy, and the care of all patients was transferred to their own physicians. Retinopathy was evaluated on the basis of centrally graded fundus photographs in 1208 patients during the fourth year after the DCCT ended, and nephropathy was evaluated on the basis of urine specimens obtained from 1302 patients during the third or fourth year, approximately half of whom were from each treatment group. RESULTS: The difference in the median glycosylated hemoglobin values between the conventional-therapy and intensive-therapy groups during the 6.5 years of the DCCT (average, 9.1 percent and 7.2 percent, respectively) narrowed during follow-up (median during 4 years, 8.2 percent and 7.9 percent, respectively, P<0.001). Nevertheless, the proportion of patients who had worsening retinopathy, including proliferative retinopathy, macular edema, and the need for laser therapy, was lower in the intensive-therapy group than in the conventional-therapy group (odds reduction, 72 percent to 87 percent, P<0.001). The proportion of patients with an increase in urinary albumin excretion was significantly lower in the intensive-therapy group. CONCLUSIONS: The reduction in the risk of progressive retinopathy and nephropathy resulting from intensive therapy in patients with type 1 diabetes persists for at least four years, despite increasing hyperglycemia.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm200002103420603

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 2

  1. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames: Iowa State University Press, 1980.
  2. Vlassara H, 1994, Lab Invest, 70, 138

Cited by

See all 1,534

Metadata

Authors
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
Corresponding author
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
Venue
New England Journal of Medicine
Published
2000-02-10
Volume
342
Issue
6
Pages
381-389
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2760585829
Cited by
1,534
References
20
Citations by year
2026: 21 · 2025: 31 · 2024: 39 · 2023: 29 · 2022: 37 · 2021: 38 · 2020: 47 · 2019: 39 · 2018: 47 · 2017: 54 · 2016: 64 · 2015: 77 · 2014: 78 · 2013: 61 · 2012: 59
FWCI
41.02
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (n01dk062204-003)
  • National Institute of Diabetes and Digestive and Kidney Diseases (N01 DK062204)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
type 1 diabetes, intensive insulin therapy, glycemic control, retinopathy, diabetic nephropathy, microvascular complications, diabetic retinopathy progression, proliferative retinopathy, macular edema, laser photocoagulation, urinary albumin excretion, HbA1c, Diabetes Control and Complications Trial, long-term follow-up
MeSH terms
Adolescent, Adult, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Diabetic Retinopathy, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Insulin, Male, Regression Analysis, Risk, Severity of Illness Index, Incidence, Randomized Controlled Trials as Topic, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy. https://app.cochat.ai/papers/10.1056/nejm200002103420603
The paper
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. (2000). Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy. New England Journal of Medicine. https://doi.org/10.1056/nejm200002103420603

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.